NCT00894790

Celecoxib Efficacy And Safety Versus Diclofenac In Acute Pain Due To Cervical Sprain Related To A Traffic Accident

A Phase IV Open Label Randomized Multicenter Comparative Study Of Celecoxib Efficacy And Safety Versus Standard Doses Of Oral Diclofenac In Acute Pain Due To Cervical Sprain Related To Motor Vehicle Accident

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 8 (actual)
• Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This Study Will Evaluate Celecoxib Efficacy And Safety Versus Standard Doses Of Diclofenac In Acute Pain Due To Cervical Injury (Due To A Sprain) Related To A Motor Vehicle Accident

Detailed description

On 21Oct2010 study was prematurely terminated due to poor enrollment with subsequent low number of participants. No safety or efficacy issues were involved in the decision to terminate prematurely.

Conditions

• Pain

Interventions

Type	Name	Description
DRUG	Celecoxib	celecoxib 200 mg BID (twice a day) with a loading dose of 400 mg
DRUG	oral Diclofenac	diclofenac 75 mg tablet BID (twice a day)

Timeline

• Start date: 2009-11-01
• Primary completion: 2010-01-01
• Completion: 2010-01-01
• First posted: 2009-05-07
• Last updated: 2021-02-02
• Results posted: 2011-02-25

Locations

2 sites across 1 country: Mexico